Literature DB >> 22170315

Increased pro-inflammatory cytokine production in Down Syndrome children upon stimulation with live influenza A virus.

Chantal J M Broers1, Reinoud J B J Gemke, Michel E Weijerman, Koen F van der Sluijs, A Marceline van Furth.   

Abstract

PURPOSE: Children with down syndrome (DS) have an increased susceptibility to infections, due to altered humoral and/or cellular immunity. The aim of this study was to determine the cytokine production in whole blood of children with DS upon stimulation with live influenza A virus.
METHODS: Whole blood of 61 children with DS and 57 of their healthy siblings was stimulated with 2.5 × 10(4) TCID50/ml influenza A virus during 6, 24, and 48 h. TNF-α, IL-1β, IL-6, IL-8, IL-10, IL-12p70, IFN-α, IFN-γ concentrations, and viral load were measured at all time points.
RESULTS: At most of the time points, TNF-α, IL-1β, IL-6, and IL-8 concentrations were significantly higher in children with DS following stimulation with live influenza A virus. IFN-α and IFN-γ levels were also significantly higher in the DS group. Viral clearance, however, was equal in both groups.
CONCLUSIONS: Children with DS have an altered immune response to influenza A virus. The production of higher levels of pro-inflammatory cytokines may be responsible for a more severe clinical course of viral disease in these children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170315     DOI: 10.1007/s10875-011-9625-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

1.  Distinct abnormalities in the innate immune system of children with Down syndrome.

Authors:  Beatrijs L P Bloemers; Grada M van Bleek; Jan L L Kimpen; Louis Bont
Journal:  J Pediatr       Date:  2010-02-20       Impact factor: 4.406

2.  Intrinsic abnormalities of lymphocyte counts in children with down syndrome.

Authors:  Yvette C M de Hingh; Petrus W van der Vossen; Eugenie F A Gemen; André B Mulder; Wim C J Hop; Frank Brus; Esther de Vries
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

3.  Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers.

Authors:  A Cossarizza; D Monti; G Montagnani; C Ortolani; M Masi; M Zannotti; C Franceschi
Journal:  Am J Med Genet Suppl       Date:  1990

4.  A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection.

Authors:  Keer Sun; Luisa Torres; Dennis W Metzger
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

5.  Influences of interferon-gamma on cell proliferation and interleukin-6 production in Down syndrome derived fibroblasts.

Authors:  Tsutomu Iwamoto; Aya Yamada; Kenji Yuasa; Emiko Fukumoto; Takashi Nakamura; Taku Fujiwara; Satoshi Fukumoto
Journal:  Arch Oral Biol       Date:  2009-08-22       Impact factor: 2.633

6.  Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes.

Authors:  Maaike A A Kusters; Eugenie F A Gemen; Ruud H J Verstegen; Peter C Wever; Esther DE Vries
Journal:  Pediatr Res       Date:  2010-05       Impact factor: 3.756

7.  Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study.

Authors:  Beatrijs L P Bloemers; A Marceline van Furth; Michel E Weijerman; Reinoud J B J Gemke; Chantal J M Broers; Kimberly van den Ende; Jan L L Kimpen; Jan L M Strengers; Louis J Bont
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

Review 8.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

9.  Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.

Authors:  Suki M Y Lee; Jennifer L Gardy; C Y Cheung; Timothy K W Cheung; Kenrie P Y Hui; Nancy Y Ip; Y Guan; Robert E W Hancock; J S Malik Peiris
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

10.  Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus.

Authors:  Koenraad F van der Sluijs; Leontine van Elden; Monique Nijhuis; Rob Schuurman; Sandrine Florquin; Henk M Jansen; René Lutter; Tom van der Poll
Journal:  Immunol Lett       Date:  2003-10-31       Impact factor: 3.685

View more
  14 in total

1.  Immune-related conditions and acute leukemia in children with Down syndrome: a Children's Oncology Group report.

Authors:  Amy M Linabery; Wenchao Li; Michelle A Roesler; Logan G Spector; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-10       Impact factor: 4.254

2.  Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome.

Authors:  Rita Carsetti; Diletta Valentini; Valentina Marcellini; Marco Scarsella; Emiliano Marasco; Ferruccio Giustini; Andrea Bartuli; Alberto Villani; Alberto G Ugazio
Journal:  Eur J Immunol       Date:  2014-12-28       Impact factor: 5.532

3.  Pathogenic potential of interferon αβ in acute influenza infection.

Authors:  Sophia Davidson; Stefania Crotta; Teresa M McCabe; Andreas Wack
Journal:  Nat Commun       Date:  2014-05-21       Impact factor: 14.919

4.  Gut microbiome in Down syndrome.

Authors:  Elena Biagi; Marco Candela; Manuela Centanni; Clarissa Consolandi; Simone Rampelli; Silvia Turroni; Marco Severgnini; Clelia Peano; Alessandro Ghezzo; Maria Scurti; Stefano Salvioli; Claudio Franceschi; Patrizia Brigidi
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

5.  Prevalence of celiac disease in patients with Down syndrome: a meta-analysis.

Authors:  Yang Du; Ling-Fei Shan; Zong-Ze Cao; Jin-Chao Feng; Yong Cheng
Journal:  Oncotarget       Date:  2017-12-23

6.  Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis.

Authors:  Yan Zhang; Meng Che; Jing Yuan; Yun Yu; Chang Cao; Xiao-Yan Qin; Yong Cheng
Journal:  Oncotarget       Date:  2017-09-19

Review 7.  Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome.

Authors:  Tomer Illouz; Arya Biragyn; Maria Florencia Iulita; Lisi Flores-Aguilar; Mara Dierssen; Ilario De Toma; Stylianos E Antonarakis; Eugene Yu; Yann Herault; Marie-Claude Potier; Alexandra Botté; Randall Roper; Benjamin Sredni; Jacqueline London; William Mobley; Andre Strydom; Eitan Okun
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

Review 8.  OxInflammation: From Subclinical Condition to Pathological Biomarker.

Authors:  Giuseppe Valacchi; Fabio Virgili; Carlo Cervellati; Alessandra Pecorelli
Journal:  Front Physiol       Date:  2018-07-09       Impact factor: 4.566

9.  Interleukin 6 and 10 Serum Levels and Genetic Polymorphisms in Children with Down Syndrome.

Authors:  Marlon Fraga Mattos; Patrícia Matos Biselli-Chicote; Joice Matos Biselli; Thiago Luís da Silva Assembleia; Eny Maria Goloni-Bertollo; Érika Cristina Pavarino
Journal:  Mediators Inflamm       Date:  2018-08-16       Impact factor: 4.711

Review 10.  Down Syndrome and COVID-19: A Perfect Storm?

Authors:  Joaquin M Espinosa
Journal:  Cell Rep Med       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.